Arrowhead Pharmaceuticals Inc. buy Piper Sandler
Start price
08.10.24
/
50%
€16.42
Target price
08.10.25
€56.53
Performance (%)
91.78%
End price
09.10.25
€31.49
Summary
This prediction ended on 09.10.25 with a price of €31.49. The BUY prediction by Piper_Sandler for Arrowhead Pharmaceuticals Inc. saw massive gains of 91.78%. Piper_Sandler has a follow-up prediction for Arrowhead Pharmaceuticals Inc. where he still thinks Arrowhead Pharmaceuticals Inc. is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 13.154% | 13.154% | 182.136% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Piper_Sandler for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $62.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€34.14
19.11.25
19.11.25
€60.47
19.11.26
19.11.26
74.87%
12.12.25
12.12.25
Stopped prediction by Piper_Sandler for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.00
27.11.24
27.11.24
€42.54
27.11.25
27.11.25
100.00%
28.11.25
28.11.25